0.9% Sodium Chloride Injection, USP, 250 mL single dose Flexible Plastic Container, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-7983-02
Published June 26, 2013 · Recall initiated: June 6, 2013
Summary
FDA records drug Class II recall D-608-2013, published June 26, 2013 and initiated June 6, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 676,872 containers; Lot: Lot #: 16-031-JT*, Exp 1APR2014; Note the * may be followed by 01 or 02. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: The product has the potential for solution to leak at or near the administrative port of the primary container.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot #: 16-031-JT*, Exp 1APR2014; Note the * may be followed by 01 or 02
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAInfant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, RxMay 31, 2017
- FDAMinibore Extension Set, 59 Inch with Spin Lock Collar, Non-DEHP, Latex-Free Intended use: For theJanuary 18, 2017
- FDAFentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira, Inc., LakeNovember 30, 2016
- FDASymbiq Two Channel Infuser; an Rx medical device infusion pump used to administer I.V. fluids. List numberNovember 16, 2016
- FDANorpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottlesJune 26, 2013
- FDACleocin Phosphate (clindamycin Injection), USP, a) 600 mg/4mL (150 mg/mL) ADD-Vantage Vial, b) 900 mg/6mL (150June 26, 2013
Questions about this recall
Was 0.9% Sodium Chloride Injection, USP, 250 mL single dose Flexible Plastic Container, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-7983-02 recalled?
Yes. FDA published recall D-608-2013 on June 26, 2013. Reported hazard: Lack of Assurance of Sterility: The product has the potential for solution to leak at or near the administrative port of the primary container.
What should I do if I have this product?
Voluntary: Firm initiated · Letter